Who
Joseph D. Keegan
Director
Company insider
Files Form 4 as: Director, Interpace Biosciences; Director, Bio-Techne; Director, Response Biomedical; Director, Stereotaxis; Director, Alpha Innotech; CEO/President, Molecular Devices.
In numbers
- Trades disclosed
- 135
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $2.7M
- Companies
- 6
- Companies where not an officer
- 5
- First trade
- 29 Jul 2005
- Last trade
- 20 Aug 2026
- Last filed
- 20 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Aug 2026filed 20 Aug 2026 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —69,252 at $0.00 | filing |
| 20 Aug 2026filed 20 Aug 2026 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —69,252 at $0.00 | filing |
| 30 Oct 2025filed 3 Nov 2025 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —3,777 at $0.00 | filing |
| 30 Oct 2025filed 3 Nov 2025 | TECH Bio-TechneLife-science tools | SEC FORM 4 Code A | —1,640 at $0.00 | filing |
| 24 Oct 2024filed 28 Oct 2024 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —3,511 at $0.00 | filing |
| 24 Oct 2024filed 28 Oct 2024 | TECH Bio-TechneLife-science tools | SEC FORM 4 Code A | —1,462 at $0.00 | filing |
| 26 Oct 2023filed 30 Oct 2023 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —3,937 at $0.00 | filing |
| 26 Oct 2023filed 30 Oct 2023 | TECH Bio-TechneLife-science tools | SEC FORM 4 Code A | —1,625 at $0.00 | filing |
| 27 Oct 2022filed 31 Oct 2022 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —865 at $0.00 | filing |
| 27 Oct 2022filed 31 Oct 2022 | TECH Bio-TechneLife-science tools | SEC FORM 4 Code A | —338 at $0.00 | filing |
| 28 Oct 2021filed 1 Nov 2021 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —633 at $0.00 | filing |
| 28 Oct 2021filed 1 Nov 2021 | TECH Bio-TechneLife-science tools | SEC FORM 4 Code A | —194 at $0.00 | filing |
| 29 Oct 2020filed 2 Nov 2020 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —1,507 at $0.00 | filing |
| 29 Oct 2020filed 2 Nov 2020 | TECH Bio-TechneLife-science tools | SEC FORM 4 Code A | —391 at $0.00 | filing |
| 9 Jul 2020filed 10 Jul 2020 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —29,000 at $0.00 | filing |
| 24 Oct 2019filed 28 Oct 2019 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —2,011 at $0.00 | filing |
| 24 Oct 2019filed 28 Oct 2019 | TECH Bio-TechneLife-science tools | SEC FORM 4 Code A | —495 at $0.00 | filing |
| 25 Oct 2018filed 29 Oct 2018 | TECH Bio-TechneLife-science tools | SEC FORM 4 Code A | —514 at $0.00 | filing |
| 25 Oct 2018filed 29 Oct 2018 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —1,898 at $0.00 | filing |
| 7 Mar 2018filed 9 Mar 2018 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —19,200 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.